Kanghua Biology (SHE: 300841)

OTHER
Chengdu, Sichuan, China
Website

Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.

Total Investments
0
Portfolio Companies
0
Exits
0
Funds
0
Investment Focus

View 5 investors free

Create a free account to unlock Kanghua Biology (SHE: 300841)'s AUM, portfolio companies, fund details, and deal history.

No credit card required